Analysis of the prognosis of patients with testicular seminoma
- Authors:
- Wei Dong
- Wang Gang
- Miaomiao Liu
- Hongzhen Zhang
View Affiliations
Affiliations: Department of Urology, Hebei People's Hospital, Shijiazhuang, Hebei 050051, P.R. China, Department of Fifth Oncology, Hebei People's Hospital, Shijiazhuang, Hebei 050051, P.R. China
- Published online on: December 30, 2015 https://doi.org/10.3892/ol.2015.4065
-
Pages:
1361-1366
-
Copyright: © Dong
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Testicular seminoma is a common malignancy, accounting for 35‑50% of testicular tumors. Comprehensive therapies lead to good curative efficacy. However, the factors that affect prognosis remain to be elucidated. The aim of the present study was to analyze the 3‑, 5‑ and 10‑year survival rate of patients with testicular seminoma as well as the associated factors of prognosis. The clinical data from 58 patients diagnosed with testicular seminoma were collected betweeen January 1999 and January 2014. The survival rate for this group was evaluated using the Kaplan‑Meier method. Associated factors of prognosis were analyzed using the log‑rank test. The results showed that approximately 62.1% of the cases were in the 30‑ to 50‑year age group. From this age group, 94.8% of patients survived for 3 years, 86.2% for 5 years and 70.7% for 10 years. A significant difference was identified for the different clinical stages, pathological types and postoperative treatment in the 3‑, 5‑ and 10‑year survival rates (P<0.05). In conclusion, the clinical stages, pathological types and postoperative treatments significantly affect the prognosis of testicular seminoma. Selection of an appropriate method of treatment including the clinical stages and histological types, is the key element in testicular seminoma therapy.
View References
|
1
|
Chung P, Daugaard G, Tyldesley S, Atenafu
EG and Panzarella T: Evaluation of a prognostic model for risk of
relapse in stage I seminoma surveillance. J Cancer Med. 4:155–160.
2015.(In Chinese). View
Article : Google Scholar
|
|
2
|
Travis LB, Beard C, Allan JM, Dahl AA,
Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan
R, et al: Testicular cancer survivorship: research strategies and
recommendations. J Natl Cancer Inst. 102:1114–1130. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Fu J, Lin H and Gong P: Clinical
pathology and diagnostic analysis on 15 cases of infantile
testicular germ cell tumors. Natl J Androl. 19:90–93. 2013.(In
Chinese).
|
|
4
|
Shanmugalingam T, Soultati A, Chowdhury S,
Rudman S and Van Hemelrijck M: Global incidence and outcome of
testicular cancer. Clin Epidemiol. 5:417–427. 2013.PubMed/NCBI
|
|
5
|
Zheng LW, Li FB, Liu RZ, Ji RG and Zhao
ZW: Clinical analysis of 87 cases of testicular tumor. Zhonghua Nan
Ke Xue. 11:445–447. 2005.(In Chinese). PubMed/NCBI
|
|
6
|
Song H and Huang C: Clinical analysis on
children testicular tumor (attached 55 case reports). Chin J Urol.
25:44–46. 2004.(In Chinese).
|
|
7
|
Shu B, Liu D, Huxila D, Du X and Chen P:
Multiple factor analysis on the prognosis of 110 cases with
testicular germ cell tumors. J Clin Urol. 26:528–531. 2011.(In
Chinese).
|
|
8
|
Ugwumba FO and Aghaji AE: Testicular
cancer: Management challenges in an African developing country. S
Afr Med J. 100:452–455. 2010.PubMed/NCBI
|
|
9
|
Zhang X, Liu Z, Zhou F, Han H, Qin Z and
Ye Y: A summary of 10-year experience in treating stage I
testicular seminoma. Cancer. 29:98–101. 2010.
|
|
10
|
Fucheng L: Clinical study on stage II
testicular seminoma. J Contemp Urol Reprod Oncol. 1:279–281.
2009.(In Chinese).
|
|
11
|
Mead GM, Fossa SD, Oliver RT, Joffe JK,
Huddart RA, Roberts JT, Pollock P, Gabe R and Stenning SP:
MRC/EORTC seminoma trial collaborators: Randomized trials in 2466
patients with stage I seminoma: patterns of relapse and follow-up.
J Natl Cancer Inst. 103:241–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang S and Wang C: Anlysis on the survival
rate after testicle partial excision for 1, 3, 5 years of patients
with testicular germ cell tumors. Chin J Hum Sex. 23:52–54.
2014.(In Chinese).
|
